Antifungal susceptibility testing of Malva parviflora yield extracts, against C. albicans and A. fumigatus
Main Article Content
Abstract
The increasing on the incidence of drug-resistant pathogens has drawn the attention of
researchers towards screening the antimicrobial action of plant-derived compound. This
study aimed to determine the antifungal activity of Malva parviflora extracts, which is
widespread and used by the general population in Libya. Extraction was carried out using a
cold maceration method by several different polarity solvents (petroleum ether, ethyl
acetate, methanol and distilled water). Their total-phenolic and flavonoid content were
assessed. The content of total phenolic and flavonoids were found to be the highest in
petroleum ether fraction extract (119.558mg GAEg-1) and (227.029mg RU g-1)
respectively. The antioxidant activity was estimated using DPPH as free radical scavenging
and sugar reducing power. The methanol fraction extract displayed the highest IC50 (50
mg/ml). The results indicate that the increase in the percentage of DPPH free radical
inhibition is directly proportional with the increase in the extract concentration. Reducing
power increased with the increase on extracts concentration. M. parviflora leave extracts
were tested against fungal species Aspergillus. fumigatus and Candida. albicans using
antifungal susceptibility assay of yeast and filamentous fungi. Extracts had strong
antifungal activity against C. albicans and A. fumigates. Petroleum ether fraction extract
has the strongest antifungal activity against A. fumigatus with 94.96% percentage of
inhibition. The percentage of inhibition is 96.48% was shown against C. albicans for
aqueous extract.
Article Details
References
EFERENCES
Caesar, L. K. and Cech, N. B. (2019) ‘Synergy and
antagonism in natural product extracts: When 1 + 1 does
not equal 2’, Natural Product Reports. doi:
1039/c9np00011a.
Ahmad, S. A. and Askari, A. A. (2015) ‘Ethnobotany of
the hawraman Region of Kurdistan Iraq’, Harvard
Papers in Botany. doi: 10.3100/hpib.v20iss1.2015.n8.
Abdallah, E. M. (2011) ‘Plants: An alternative source
for antimicrobials’, Journal of Applied Pharmaceutical
Science.
Pfaller, M. A. and Diekema, D. J. (2004) ‘Rare and
emerging opportunistic fungal pathogens: Concern for
resistance beyond Candida albicans and Aspergillus
fumigatus’, Journal of Clinical Microbiology, 42(10),
pp. 4419–4431. doi: 10.1128/JCM.42.10.4419-
2004.
CLSI (2008) ‘Reference method for broth dilution’,
Reference method for broth dilution antifungal
susceptibility testing of yeasts. Approved standard, 3th
ed., 28(14), pp. 0–13.
Vermeersch, M. et al. (2009) ‘In vitro susceptibilities
of Leishmania donovani promastigote and amastigote
stages to antileishmanial reference drugs: Practical
relevance of stage-specific differences’, Antimicrobial
Agents and Chemotherapy. doi: 10.1128/AAC.00548-
Evans, W. C. (1998) Trease and Evans
Pharamagonosy, WB Saunders and Company,
London.
Kokate, A. (1999) ‘Phytochemical Methods’, in
Phytotherapy, pp. 126–129.
Singleton V.L., Orthofer R., Lamuela-Raventos R.M.
Analysis of total phenols and other oxidation
substrates and antioxidants by means of FolinCiocalteu reagent. Method Enzymol. 1999;299:152–
Zhishen, J., Mengcheng, T. and Jianming, W. (1999)
‘The determination of flavonoid contents in mulberry
and their scavenging effects on superoxide radicals’,
Food Chemistry. doi: 10.1016/S0308-8146(98)00102-
Anand, U. et al. (2019) ‘A comprehensive review on
medicinal plants as antimicrobial therapeutics:
Potential avenues of biocompatible drug discovery’,
Metabolites. doi: 10.3390/metabo9110258.
Vermeersch, M. et al. (2009) ‘In vitro susceptibilities
of Leishmania donovani promastigote and amastigote
stages to antileishmanial reference drugs: Practical
relevance of stage-specific differences’, Antimicrobial
Agents and Chemotherapy. doi: 10.1128/AAC.00548-
Oyebode, O. et al. (2016) ‘Use of traditional medicine
in middle-income countries: A WHO-SAGE study’,
Health Policy and Planning. doi:
1093/heapol/czw022.
Pfaller, M. A. and Diekema, D. J. (2004) ‘Rare and
emerging opportunistic fungal pathogens: Concern for
resistance beyond Candida albicans and Aspergillus
fumigatus’, Journal of Clinical Microbiology, 42(10),
pp. 4419–4431. doi: 10.1128/JCM.42.10.4419-
2004.
Caesar, L. K. and Cech, N. B. (2019) ‘Synergy and
antagonism in natural product extracts: When 1 + 1
does not equal 2’, Natural Product Reports. doi:
1039/c9np00011a.
Balouiri, M., Sadiki, M. and Ibnsouda, S. K. (2016)
‘Methods for in vitro evaluating antimicrobial activity:
A review’, Journal of Pharmaceutical Analysis. doi:
1016/j.jpha.2015.11.005